Extrait

Background and study aims Chronic obstructive pulmonary disease (COPD) is the name given to a collection of diseases which affect the lungs. It is characterised by breathlessness, cough and excess mucus production and is often caused by smoking. Many people with chronic obstructive pulmonary disease (COPD) are affected by anxiety and/or depression and their illness can feel burdensome both physically and emotionally. One main treatment for patients with COPD is pulmonary rehabilitation (PR); a program of exercise, education and support that is used in patients with COPD to help them improve their physical condition. PR aims to help break the cycle of physical disability, associated anxiety, despondency, inactivity and isolation. Although PR is known to be an effective treatment for COPD, many patients unfortunately do not take part in or complete treatment programs, particularly those with anxiety and depression. This study is looking at a cognitive behavioural approach (CBA) program (a type of mental health therapy which aims to help people change the way they think and behave), which links into and enhances the benefits of PR, with the aim of reducing mild/moderate anxiety and/or depression in people with moderate to severe COPD. Who can participate? Adult patients with COPD who have mild anxiety and/or depression and their carers. What does the study involve? Participants are randomly allocated to one of two groups. Those in the first group receive usual care only. Those in the second group receive the CBA treatment program. This involves between five and eight 30-40 minute weekly sessions from trained respiratory health care professionals. 10-15 minute weekly telephone follow ups are also scheduled with patients if they decide to attend the PR programme after completion of the CBA intervention. At the start of the study and then after six and 12 months, participants in both groups are followed up to assess their anxiety and/or depression levels. In addition, carers of patient participants are also invited to the join the study (with patient permission) and are interviewed about their experiences of being a carer and their mental wellbeing. What are the possible benefits and risks of participating? There are no direct benefits of taking part in the trial but the information collected and feedback provided will help to improve the care of people with COPD in future. There are no notable risks involved for those taking part in the study, however, if during the one-to-one sessions or interview a participant says something that may indicate a risk to themselves or others, their GP or other healthcare professional will be contacted so appropriate arrangements can be made. Where is the study run from? Pulmonary rehabilitation (PR) services within NHS Trusts in England (UK) When is the study starting and how long is it expected to run for? November 2013 to July 2020 Who is funding the study? National Institute for Health Research (UK) Who is the main contact? 1. Ms Ratna Sohanpal (public) [email protected] 2. Professor Stephanie Taylor (scientific) [email protected]

Critère d'inclusion

• Specialty: Respiratory disorders, Primary sub-specialty: Respiratory disorders; UKCRC code/ Disease: Respiratory/ Chronic lower respiratory diseases, Mental Health/ Mood [affective] disorders

Liens

• isrctn